Anne J. Gonzales-Luna
Anne J. Gonzales-Luna
University of Houston College of Pharmacy
Verified email at - Homepage
Cited by
Cited by
Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on …
S Johnson, V Lavergne, AM Skinner, AJ Gonzales-Luna, KW Garey, ...
Clinical infectious diseases 73 (5), e1029-e1044, 2021
Clostridioides difficile ribotype 106: A systematic review of the antimicrobial susceptibility, genetics, and clinical outcomes of this common worldwide strain
TJ Carlson, D Blasingame, AJ Gonzales-Luna, F Alnezary, KW Garey
Anaerobe 62, 102142, 2020
Genetic Mechanisms of Vancomycin Resistance in Clostridioides difficile: A Systematic Review
TA Eubank, AJ Gonzales-Luna, JG Hurdle, KW Garey
Antibiotics 11 (2), 258, 2022
Reduced Susceptibility to Metronidazole Is Associated With Initial Clinical Failure in Clostridioides difficile Infection
AJ Gonzales-Luna, AO Olaitan, WJ Shen, A Deshpande, TJ Carlson, ...
Open forum infectious diseases 8 (8), ofab365, 2021
PCR ribotypes of Clostridioides difficile across Texas from 2011 to 2018 including emergence of ribotype 255
AJ Gonzales-Luna, TJ Carlson, KM Dotson, K Poblete, G Costa, ...
Emerging Microbes & Infections 9 (1), 341-347, 2020
Ultrasensitive and quantitative toxin measurement correlates with baseline severity, severe outcomes, and recurrence among hospitalized patients with Clostridioides difficile …
CD Alonso, CP Kelly, KW Garey, AJ Gonzales-Luna, D Williams, ...
Clinical Infectious Diseases 74 (12), 2142-2149, 2022
Clostridioides (Formerly Clostridium) difficile Infection During Hospitalization Increases the Likelihood of Nonhome Patient Discharge
KR Reveles, KM Dotson, A Gonzales-Luna, D Surati, BT Endres, MJ Alam, ...
Clinical Infectious Diseases 68 (11), 1887-1893, 2019
Integrating gut microbiome and host immune markers to understand the pathogenesis of Clostridioides difficile infection
S Ke, NR Pollock, XW Wang, X Chen, K Daugherty, Q Lin, H Xu, ...
Gut microbes 13 (1), 1935186, 2021
Assessment of quality of life among patients with recurrent Clostridioides difficile infection treated with investigational oral microbiome therapeutic SER-109: secondary …
KW Garey, J Jo, AJ Gonzales-Luna, B Lapin, A Deshpande, E Wang, ...
JAMA Network Open 6 (1), e2253570-e2253570, 2023
Efficacy, Safety, Pharmacokinetics, and Microbiome Changes of Ibezapolstat in Adults with Clostridioides difficile Infection: A Phase 2a Multicenter Clinical Trial
KW Garey, J McPherson, AQ Dinh, C Hu, J Jo, W Wang, CK Lancaster, ...
Clinical Infectious Diseases 75 (7), 1164-1170, 2022
Decoding a cryptic mechanism of metronidazole resistance among globally disseminated fluoroquinolone-resistant Clostridioides difficile
AO Olaitan, C Dureja, MA Youngblom, MA Topf, WJ Shen, ...
Nature Communications 14 (1), 4130, 2023
A randomized, double-blind, placebo-controlled, single and multiple ascending dose Phase 1 study to determine the safety, pharmacokinetics and food and faecal microbiome …
KW Garey, K Begum, C Lancaster, A Gonzales-Luna, D Bui, J Mercier, ...
Journal of Antimicrobial Chemotherapy 75 (12), 3635-3643, 2020
Eosinopenia and Binary Toxin Increase Mortality in Hospitalized Patients With Clostridioides difficile Infection
TJ Carlson, BT Endres, J Le Pham, AJ Gonzales-Luna, FS Alnezary, ...
Open forum infectious diseases 7 (1), ofz552, 2020
Ridinilazole for the treatment of Clostridioides difficile infection
TJ Carlson, BT Endres, E Bassères, AJ Gonzales-Luna, KW Garey
Expert opinion on investigational drugs 28 (4), 303-310, 2019
Epidemic Clostridioides difficile Ribotype 027 Lineages: Comparisons of Texas Versus Worldwide Strains
BT Endres, K Begum, H Sun, ST Walk, A Memariani, C Lancaster, ...
Open forum infectious diseases 6 (2), ofz013, 2019
Emerging Options for the Prevention and Management of Clostridioides difficile Infection
AJ Gonzales-Luna, TJ Carlson, KW Garey
Drugs 83 (2), 105-116, 2023
Toxin A–Predominant Pathogenic Clostridioides difficile: A Novel Clinical Phenotype
Q Lin, NR Pollock, A Banz, A Lantz, H Xu, L Gu, DN Gerding, KW Garey, ...
Clinical Infectious Diseases 70 (12), 2628-2633, 2020
Gut microbiota changes associated with Clostridioides difficile infection and its various treatment strategies
AJ Gonzales-Luna, TJ Carlson, KW Garey
Gut Microbes 15 (1), 2223345, 2023
In Vitro Activity of Omadacycline, a New Tetracycline Analog, and Comparators against Clostridioides difficile
K Begum, E Bassères, J Miranda, C Lancaster, AJ Gonzales-Luna, ...
Antimicrobial Agents and Chemotherapy 64 (8), 10.1128/aac. 00522-20, 2020
Antibiotic Treatment Pipeline for Clostridioides difficile Infection (CDI): A Wide Array of Narrow-Spectrum Agents
TJ Carlson, AJ Gonzales-Luna
Current Infectious Disease Reports 22, 1-11, 2020
The system can't perform the operation now. Try again later.
Articles 1–20